CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 242 enrolled
Drug / intervention
Mitomycin C +2 moredrug
Likely dose
Mitomycin C 0.4 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00666237
NCT00666237Phase 4Completed

Primary Tube Versus Trabeculectomy Study

University of Miami·interventional·Posted Apr 24, 2008·Updated Oct 19, 2022

In Brief

A Phase 4 clinical trial evaluating Tube shunt surgery, Trabeculectomy, and 1 other intervention for Glaucoma. Completed, enrolled 242 participants across 16 sites in 3 countries.

Detailed Summary

The purpose of the Primary Tube Versus Trabeculectomy (PTVT) Study is to compare the long-term safety and efficacy of nonvalved tube shunt surgery to trabeculectomy with mitomycin C in eyes that have not had previous ocular surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma
CountriesCanada, United Kingdom, United States

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 24, 2008
Enrollment StartApr 1, 2008
Primary CompletionApr 1, 2021
TodayJul 2, 2026
Enrollment to primary: 13 yearsPosted 18.2 years ago

Interventions

Tube shunt surgeryprocedure

The procedure involves implantation of a Baerveldt consisting of a tube that is connected to an end plate. The tube is inserted into the anterior chamber and shunts aqueous humor to the end plate located in the equatorial region of the eye. The aqueous humor is then absorbed by the tissues around the eye.

Trabeculectomyprocedure

The procedure involves removal of a small portion of trabecular meshwork and adjacent tissue under a partial thickness scleral flap. Aqueous humor drains into the subconjunctival space producing a filtering bleb. The aqueous humor then diffuse out of the bleb.

Mitomycin Cdrug

A fluid retaining sponge soaked in 0.4 mg/ml Mitomycin C will be applied in the region of Trabeculectomy site for about 2 minutes